• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向固醇O-酰基转移酶1以破坏胆固醇代谢用于癌症治疗。

Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapy.

作者信息

Tu Teng, Zhang Hongying, Xu Huanji

机构信息

Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, Chengdu, China.

Laboratory of Oncogene, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Oncol. 2023 Jun 20;13:1197502. doi: 10.3389/fonc.2023.1197502. eCollection 2023.

DOI:10.3389/fonc.2023.1197502
PMID:37409263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10318190/
Abstract

Cholesterol esterification is often dysregulated in cancer. Sterol O-acyl-transferase 1 (SOAT1) plays an important role in maintaining cellular cholesterol homeostasis by catalyzing the formation of cholesterol esters from cholesterol and long-chain fatty acids in cells. Many studies have implicated that SOAT1 plays a vital role in cancer initiation and progression and is an attractive target for novel anticancer therapy. In this review, we provide an overview of the mechanism and regulation of SOAT1 in cancer and summarize the updates of anticancer therapy targeting SOAT1.

摘要

胆固醇酯化在癌症中常常失调。固醇O-酰基转移酶1(SOAT1)通过催化细胞内胆固醇与长链脂肪酸形成胆固醇酯,在维持细胞胆固醇稳态中发挥重要作用。许多研究表明,SOAT1在癌症的发生和发展中起着至关重要的作用,是新型抗癌治疗的一个有吸引力的靶点。在这篇综述中,我们概述了SOAT1在癌症中的作用机制和调控,并总结了针对SOAT1的抗癌治疗的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50e/10318190/a9a17bd802c3/fonc-13-1197502-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50e/10318190/a9a17bd802c3/fonc-13-1197502-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50e/10318190/a9a17bd802c3/fonc-13-1197502-g001.jpg

相似文献

1
Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapy.靶向固醇O-酰基转移酶1以破坏胆固醇代谢用于癌症治疗。
Front Oncol. 2023 Jun 20;13:1197502. doi: 10.3389/fonc.2023.1197502. eCollection 2023.
2
Targeting Sterol -Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential.靶向甾醇-酰基转移酶/酰基辅酶A:胆固醇酰基转移酶(ACAT):小分子抑制剂及其治疗潜力的展望
J Med Chem. 2022 Dec 22;65(24):16062-16098. doi: 10.1021/acs.jmedchem.2c01265. Epub 2022 Dec 6.
3
Ceramide-mediated gut dysbiosis enhances cholesterol esterification and promotes colorectal tumorigenesis in mice.鞘氨醇介导的肠道菌群失调增强胆固醇酯化作用并促进小鼠结直肠肿瘤发生。
JCI Insight. 2022 Feb 8;7(3):e150607. doi: 10.1172/jci.insight.150607.
4
P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis.p53 缺失影响胆固醇酯化作用,从而加重肝癌的发生。
Hepatology. 2023 May 1;77(5):1499-1511. doi: 10.1002/hep.32518. Epub 2023 Apr 17.
5
SOAT1 enhances lung cancer invasiveness by stimulating AKT-mediated mitochondrial fragmentation.SOAT1通过刺激AKT介导的线粒体分裂来增强肺癌的侵袭性。
Biochem Cell Biol. 2022 Feb;100(1):68-74. doi: 10.1139/bcb-2021-0175. Epub 2021 Oct 20.
6
High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer.固醇-O-酰基转移酶 1(SOAT1)表达水平升高与胆固醇代谢有关,与高危前列腺癌的早期生化复发相关。
Prostate Cancer Prostatic Dis. 2022 Sep;25(3):484-490. doi: 10.1038/s41391-021-00431-3. Epub 2021 Jul 29.
7
Embryonic cholesterol esterification is regulated by a cyclic AMP-dependent pathway in yolk sac membrane-derived endodermal epithelial cells.胚胎胆固醇酯化由卵黄囊膜来源的内胚层上皮细胞中的环磷酸腺苷依赖性途径调控。
PLoS One. 2017 Nov 21;12(11):e0187560. doi: 10.1371/journal.pone.0187560. eCollection 2017.
8
High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth.高亲和力 SOAT1 配体重塑胆固醇代谢程序以抑制肿瘤生长。
BMC Med. 2022 Aug 9;20(1):292. doi: 10.1186/s12916-022-02436-8.
9
Extra-hepatic metabolism of 7-ketocholesterol occurs by esterification to fatty acids via cPLA2α and SOAT1 followed by selective efflux to HDL.7-酮胆固醇的肝外代谢通过cPLA2α和SOAT1将其酯化为脂肪酸,随后选择性流出至高密度脂蛋白(HDL)而发生。
Biochim Biophys Acta. 2015 May;1851(5):605-19. doi: 10.1016/j.bbalip.2015.01.007. Epub 2015 Jan 22.
10
Simultaneously targeting SOAT1 and CPT1A ameliorates hepatocellular carcinoma by disrupting lipid homeostasis.同时靶向SOAT1和CPT1A通过破坏脂质稳态改善肝细胞癌。
Cell Death Discov. 2021 May 29;7(1):125. doi: 10.1038/s41420-021-00504-1.

引用本文的文献

1
Frontiers in Systemic Therapy for Unresectable or Metastatic Adrenocortical Carcinoma: Harnessing Novel Therapeutic Approaches.不可切除或转移性肾上腺皮质癌的系统治疗前沿:利用新型治疗方法
Clin Med Insights Oncol. 2025 Aug 29;19:11795549251364042. doi: 10.1177/11795549251364042. eCollection 2025.
2
Metabolic Signature in Combination with Fecal Immunochemical Test as a Non-Invasive Tool for Advanced Colorectal Neoplasia Diagnosis.代谢特征联合粪便免疫化学检测作为晚期结直肠肿瘤诊断的非侵入性工具
Cancers (Basel). 2025 Jul 15;17(14):2339. doi: 10.3390/cancers17142339.
3
Evaluating cholesterol de novo synthesis biomarkers: a systematic review and meta-analysis of cancer prognosis and clinical outcomes.

本文引用的文献

1
Key events in cancer: Dysregulation of SREBPs.癌症中的关键事件:固醇调节元件结合蛋白的失调
Front Pharmacol. 2023 Mar 8;14:1130747. doi: 10.3389/fphar.2023.1130747. eCollection 2023.
2
Mechanisms driving the immunoregulatory function of cancer cells.驱动癌细胞免疫调节功能的机制。
Nat Rev Cancer. 2023 Apr;23(4):193-215. doi: 10.1038/s41568-022-00544-4. Epub 2023 Jan 30.
3
Dysregulated cholesterol regulatory genes as a diagnostic biomarker for cancer.胆固醇调节基因失调作为癌症的诊断生物标志物
评估胆固醇从头合成生物标志物:关于癌症预后和临床结局的系统评价与荟萃分析
BMC Cancer. 2025 Jul 24;25(1):1208. doi: 10.1186/s12885-025-14633-8.
4
Applying the algorithm for Proven and young in GWAS Reveals high polygenicity for key traits in Nellore cattle.在基因组全基因关联研究中应用针对已证实和年轻个体的算法,揭示了内洛尔牛关键性状的高多基因性。
Front Genet. 2025 Apr 30;16:1549284. doi: 10.3389/fgene.2025.1549284. eCollection 2025.
5
SOAT1 Activates NLRP3 Inflammasome to Promote Cancer-Related Lymphangiogenesis and Metastasis via IL-1β/IL-1R-1 Axis in Oral Squamous Cell Carcinoma.SOAT1通过IL-1β/IL-1R-1轴激活NLRP3炎性小体,促进口腔鳞状细胞癌中与癌症相关的淋巴管生成和转移。
Mol Carcinog. 2025 Jun;64(6):1039-1056. doi: 10.1002/mc.23907. Epub 2025 Mar 26.
6
Targeting ACAT1 in cancer: from threat to treatment.靶向癌症中的ACAT1:从威胁到治疗
Front Oncol. 2024 Apr 24;14:1395192. doi: 10.3389/fonc.2024.1395192. eCollection 2024.
J Gene Med. 2023 Apr;25(4):e3475. doi: 10.1002/jgm.3475. Epub 2023 Feb 5.
4
Targeting Sterol -Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential.靶向甾醇-酰基转移酶/酰基辅酶A:胆固醇酰基转移酶(ACAT):小分子抑制剂及其治疗潜力的展望
J Med Chem. 2022 Dec 22;65(24):16062-16098. doi: 10.1021/acs.jmedchem.2c01265. Epub 2022 Dec 6.
5
Drugging p53 in cancer: one protein, many targets.在癌症中靶向 p53:一种蛋白,多个靶点。
Nat Rev Drug Discov. 2023 Feb;22(2):127-144. doi: 10.1038/s41573-022-00571-8. Epub 2022 Oct 10.
6
Targeting the key cholesterol biosynthesis enzyme squalene monooxygenasefor cancer therapy.靶向关键胆固醇生物合成酶角鲨烯单加氧酶用于癌症治疗。
Front Oncol. 2022 Aug 24;12:938502. doi: 10.3389/fonc.2022.938502. eCollection 2022.
7
Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage.胶质母细胞瘤中的脂质代谢:从从头合成到储存
Biomedicines. 2022 Aug 11;10(8):1943. doi: 10.3390/biomedicines10081943.
8
High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth.高亲和力 SOAT1 配体重塑胆固醇代谢程序以抑制肿瘤生长。
BMC Med. 2022 Aug 9;20(1):292. doi: 10.1186/s12916-022-02436-8.
9
Emerging Role of Ubiquitin-Specific Protease 19 in Oncogenesis and Cancer Development.泛素特异性蛋白酶19在肿瘤发生和癌症发展中的新作用
Front Cell Dev Biol. 2022 May 12;10:889166. doi: 10.3389/fcell.2022.889166. eCollection 2022.
10
Comprehensive Analysis of as a Prognostic Biomarker and Its Association With Immune Infiltration in Glioma.作为胶质瘤预后生物标志物的综合分析及其与免疫浸润的关联
Front Oncol. 2022 May 12;12:896433. doi: 10.3389/fonc.2022.896433. eCollection 2022.